← All companies

OCUL

Ocular Therapeutix, Inc.

OCUL Nasdaq Pharmaceutical Preparations EDGAR ↗

$8.40

-0.07 -0.83%

Key statistics

from XBRL data in SEC filings

Market cap

$1.84B

Revenue (TTM)

$52.1M

Net income (TTM)

-$301M

EPS (TTM)

$-1.40

P/E ratio

—

Dividend yield

—

Free cash flow

-$217M

Cash

$599M

Total assets

$671M

Gross margin

—

52-week range

$6.23 – $16.44

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Regulation FD disclosure Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 5, 2026 8-K Results of operations (earnings release) Feb 5, 2026 8-K Director or officer change Jan 23, 2026 8-K Other events Dec 18, 2025 8-K Other events Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Entered a material agreement; Other events Sep 30, 2025 8-K Other events Sep 30, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results; Other events Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release) May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Mar 3, 2025 8-K Director or officer change Feb 14, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Director or officer change Oct 9, 2024 8-K Director or officer change Sep 3, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 14, 2024 8-K Exit or disposal costs Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Apr 18, 2024 8-K Other events Mar 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Results of operations (earnings release) Mar 11, 2024 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Director or officer change; Other events Feb 22, 2024 8-K Other events Jan 25, 2024 8-K Entered a material agreement; Other events Dec 14, 2023